Adjusted treatment COMPArisons between guSelkumab and uStekinumab for treatment of moderate‐to‐severe plaque psoriasis: the COMPASS analysis

por Diels, J., Thilakarathne, P., Cameron, C., McElligott, S., Schubert, A., Puig, L.
Publicado 2020

Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients

por Diels, J., Hamberg, P., Ford, D., Price, P. Wheatley, Spencer, M., Dass, R. N.
Publicado 2014

Soil nutrients and crop yield response to conservation-effective management practices in the sub-humid highlands agro-ecologies of Kenya

por Kiboi, M.N., Ngetich, F.K., Mucheru-Muna, M.W., Diels, J., Mugendi, D.N.
Publicado 2021

CERES-Maize model for simulating genotype-by-environment interaction of maize and its stability in the dry and wet savannas of Nigeria

por Adnan, A.A, Diels, J., Jibrin, J.M., Kamara, A.Y, Shaibu, A.S, Craufurd, P, Menkir, Abebe
Publicado 2020

Options for calibrating CERES-maize genotype specific parameters under data-scarce environments

por Adnan, A. A., Diels, J., Jibrin, J. M., Kamara, A. Y., Craufurd, P., Shaibu, A. S., Mohammed, I. B., Tonnang, Z. E. H.
Publicado 2019

P12: TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: RETROSPECTIVE CHART REVIEW OF REAL-WORLD OUTCOMES FOR STANDARD OF CARE

por Vekemans, M-C, Delforge, M, Anguille, S, Depaus, J, Meuleman, N, Van de Velde, A, Vande Broek, I, Strens, D, Van Hoorenbeeck, S, Moorkens, EJ, Diels, J, Ghilotti, F, Dalhuisen, S, Vandervennet, S
Publicado 2022

P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE L...

por Einsele, H., Moreau, P., Delforge, M., van de Donk, N. W., Ghilotti, F., Diels, J., Elsada, A., Strulev, V., Pei, L., Kobos, R., Smit, J., Slavcev, M., Weisel, K., Mateos, M.-V.
Publicado 2022

P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 A...

por Decaux, O., Hulin, C., Perrot, A., Macro, M., Frenzel, L., Diels, J., Perualila, N. J., Ghilotti, F., Haefliger, B., Goldsztajn, E., Vernet, S., Thevenon, J., Willaime, M., Texier, N., Schecter, J. M., Madduri, D., Jackson, C., Valluri, S., Moreau, P.
Publicado 2022

P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPO...

por Weisel, K., Mateos, M.-V., Vincent, L., Martin, T., Berdeja, J. G., Jakubowiak, A., Jagannath, S., Lin, Y., Thilakarathne, P., Ghilotti, F., Diels, J., Haefliger, B., Hague, C., Gonzalez, A., Schecter, J. M., Gries, K. S., Strulev, V., Nesheiwat, T., Pacaud, L., Einsele, H., Moreau, P.
Publicado 2022

P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING-ADJUSTED INDIRECT TREATMENT COMP...

por Delforge, M., Usmani, S. Z., van de Donk, N. W., Garfall, A. L., Moreau, P., Oriol, A., Nooka, A. K., Rosinol, L., Bahlis, N., Rodriguez-Otero, P., Martin, T., Diels, J., Van Sanden, S., Pei, L., Ammann, E., Kobos, R., Slavcev, M., Smit, J., Londhe, A., Krishnan, A.
Publicado 2022

PB2014: TECLISTAMAB VS SELINEXOR-DEXAMETHASONE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHING-ADJUSTED INDIRECT COMPARISON

por Rosinol, L., Usmani, S. Z., Bahlis, N., Krishnan, A. Y., Nooka, A. K., Oriol, A., Delforge, M., Garfall, A. L., van de Donk, N. W., Rodríguez Otero, P., Martin, T. G., Diels, J., Van Sanden, S., Pei, L., Ammann, E., Kobos, R., Slavcev, M., Smit, J., Londhe, A., Moreau, P.
Publicado 2022